ReachMD

Episodes 1-9 of 9

• • 

    

    Marwan Noel Sabbagh, MD, FAAN, CCRI

    Peer

  • 

    

    Alireza Atri, MD, PhD

    Peer

  7

  

  RestartResume

  New Horizons in Alzheimer’s Disease

  New Horizons in Alzheimer’s Disease

  0.25 credits

• • 

    

    Richard S. Isaacson, MD

    Peer

  • 

    

    Marc E. Agronin, MD

    Peer

  8

  

  RestartResume

  Updates in the Management of Early Alzheimer’s Disease

  Updates in the Management of Early Alzheimer’s Disease

  0.25 credits

• • 

    

    Anita L. Nelson, MD

    Peer

  18

  

  RestartResume

  Clinical & Practical Perspectives in Menopause Management

  Clinical & Practical Perspectives in Menopause Management

  0.50 credits

• • 

    

    Pradeep Y. Ramulu, MD, PhD

    Peer

  • 

    

    E. Randy Craven, MD

    Peer

  • 

    

    Mark T. Dunbar, OD, FAAO

    Peer

  8

  

  RestartResume

  Innovations in Glaucoma Therapy

  Innovations in Glaucoma Therapy

  0.25 credits

• • 

    

    Pradeep Y. Ramulu, MD, PhD

    Peer

  • 

    

    Ian Benjamin Gaddie, OD, FAAO

    Peer

  9

  

  RestartResume

  Glaucoma: Therapeutic Advances on the Cutting Edge

  Glaucoma: Therapeutic Advances on the Cutting Edge

  0.25 credits

• • 

    

    Mark Dunbar, OD, FAAO

    Peer

  • 

    

    Diana V. Do, MD

    Peer

  5

  

  RestartResume

  A National Eye Institute Initiative—Ensuring the Health of Patients and Staff in Eye Health Practices During COVID-19

  A National Eye Institute Initiative—Ensuring the Health of Patients and Staff in Eye Health Practices During COVID-19

  0.25 credits

• • 

    

    Diana Shechtman, OD, FAAO

    Peer

  • 

    

    Charles Wykoff, MD, PhD

    Peer

  3

  

  RestartResume

  A National Eye Institute Initiative—Practice Strategies to Optimize Continuity of Care for Eye Health During COVID-19

  A National Eye Institute Initiative—Practice Strategies to Optimize Continuity of Care for Eye Health During COVID-19

  0.25 credits

• • 

    

    Julio A. Ramírez, MD, FACP

    Peer

  • 

    

    Charles P. Vega, MD

    Peer

  4

  

  RestartResume

  Selección Apropiada de Terapia Antiviral Contra la Influenza

  Selección Apropiada de Terapia Antiviral Contra la Influenza

  0.25 credits

• • 

    

    Charles P. Vega, MD

    Peer

  • 

    

    Angel O. Coz Yataco, MD, FCCP

    Peer

  7

  

  RestartResume

  La Influenza: Ciencia Emergente en Pacientes de Alto Riesgo en la Población

  La Influenza: Ciencia Emergente en Pacientes de Alto Riesgo en la Población

  0.25 credits